Comprehensive multi-omics analysis provides biological insights and therapeutic strategies for small-cell lung cancer
Comprehensive multi-omics analysis provides biological insights and therapeutic strategies for small-cell lung cancer
Integration of multi-omics analysis into small-cell lung cancer (SCLC) research. In the research of small-cell lung cancer, the integration of multi-omics analysis has become an important research direction. Multi-omics analysis includes the study of genomics, transcriptomics, proteomics, metabolomics, and other levels, which can help us to understand the pathogenesis and development process of diseases more comprehensively as well as develop novel therapeutics and biomarkers for further precision oncology.
1 | Q Liu, J Zhang, C Guo, et al. Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies. Cell. 2024;187(1):184-203 e28. |
2 | W Chen, R Zheng, PD Baade, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115-132. |
3 | WJ Petty, L Paz-Ares. Emerging strategies for the treatment of small cell lung cancer: a review. JAMA Oncol. 2023;9(3):419-429. |
4 | CHY Cheung, HF Juan. Quantitative proteomics in lung cancer. J Biomed Sci. 2017;24(1):37. |
5 | J George, JS Lim, SJ Jang, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524(7563):47-53. |
/
〈 | 〉 |